Gut–Lung Microbiome Profiling and Candidate Selection
Establish an interpretable baseline for gut and respiratory microbial changes in COPD-relevant systems. Study designs may combine stool or airway microbiome sequencing, strain-specific quantification, selected metabolite assays and host inflammatory phenotyping. Probiotic candidates and FMT-derived hypotheses can be prioritized through matched controls, rather than inferred from taxonomic abundance alone.
Study scope: diversity and composition, targeted taxa, SCFA/metabolite profiles, sample timing.
Deliverables: microbial landscape, candidate shortlist and biomarker-linked hypotheses.
